This single paragraph provides significant insight into internal priorities. It confirms that, as of 2025, Health officials were actively developing options to revise statutory price-reduction mechanisms to align them with changes to the NMFG. The nature of these changes, however, remains protected via redactions. The justifications for the redactions provide useful insights.
Reread this document - even its redactions reveal that change might be coming
January 13, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News -
The leadership challenge behind Australia’s medicine access gap
March 13, 2026 - - Latest News -
Australia has spent four decades having the wrong conversation about medicines access
March 13, 2026 - - Latest News -
‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event
March 13, 2026 - - Latest News -
Australia’s top community pharmacists honoured at national awards
March 13, 2026 - - Latest News -
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Australian Biotech

